Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

45.50 +1.11 (+2.50%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Volume	2,884,998
Open	44.23
Bid (Size)	44.00 (1,100)
Ask (Size)	45.84 (100)
Prev. Close	44.39
Today's Range	43.42 - 50.88
52wk Range	41.50 - 90.32
Shares Outstanding	8,168,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

Today 17:00 EST

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-3.5%	-3.5%
1 Month	-11.1%	-11.1%
3 Month	-27.5%	-27.5%
6 Month	-48.6%	-48.6%
1 Year	-1.6%	-1.6%

More News

Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO)

December 30, 2025

From Kirby McInerney LLP

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling

December 30, 2025

Via MarketMinute

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗

December 03, 2025

Via The Motley Fool

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

December 03, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

November 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future ↗

November 11, 2025

Via Benzinga

PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗

November 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 11, 2025

Via Benzinga

SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm

November 11, 2025

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm

November 10, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

These stocks are moving in today's session ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

November 05, 2025

Via Chartmill

Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 04, 2025

Via Benzinga

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO

October 30, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 27, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?

Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?

Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?

The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market

What is the current price of Soleno Therapeutics, Inc. - Common Stock?

The current price of Soleno Therapeutics, Inc. - Common Stock is 45.50

When was Soleno Therapeutics, Inc. - Common Stock last traded?

The last trade of Soleno Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET

What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?

The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 371.68M

How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?

Soleno Therapeutics, Inc. - Common Stock has 372M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.